TCL Archive Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable January 31, 2003
TCL Archive Trial Links Potential Biomarkers To Drugs For Lung Cancer, To Help Target Therapies April 30, 2010